Dental implant with excellent osteointegration and antibacterial properties and method for producing the same
The formation of a silver-titanium oxide matrix on dental implants through a silver precursor and UV-ozone treatment addresses bacterial contamination and hydrophobicity issues, enhancing antibacterial properties and osseointegration for improved implant success.
Patent Information
- Application Number
- KR1020230083785
- Authority / Receiving Office
- KR · KR
- Patent Type
- Patents
- Current Assignee / Owner
- Filing Date
- 2023-06-28
- Publication Date
- 2026-11-06
- Estimated Expiration
- 2043-06-28
AI Technical Summary
Existing dental implants face issues with premature failure due to bacterial contamination and hydrophobic surfaces that hinder osseointegration, leading to prolonged stabilization periods and reduced fixation strength.
A method involving a silver-titanium oxide matrix formed on the implant surface through a process of supporting a titanium substrate in a silver precursor solution, followed by heating and UV-ozone treatment to create a superhydrophilic surface with a contact angle of 5° or less, enhancing antibacterial properties and osseointegration.
The method improves the antibacterial properties of dental implants by sustained release of silver ions, maintaining hydrophilicity, and promoting rapid bone fusion, thereby reducing early failure rates and increasing the success rate of implants.
Smart Images

Figure 112023071461367-PAT00003_ABST
Abstract
Description
Technology Field
[0001] The present invention relates to a dental implant with excellent osseointegration and antibacterial properties and a method for manufacturing the same. Background Technology
[0002] Dental implants are artificial teeth capable of permanently replacing missing teeth and are widely used to restore masticatory function in partially or completely edentulous areas. Therefore, implants must not only be able to functionally substitute for actual teeth but must also be manufactured to allow for long-term use by properly distributing the load applied to the teeth.
[0003] Since the fixation strength of an implant depends on the patient's bone volume and quality, it is crucial to ensure stability after implantation. Implant stability is expressed as the sum of primary stability, which arises from the implant's contact with the surrounding bone, and secondary stability, which is achieved through the formation of new bone tissue and osseointegration following placement. In particular, improving early stability after implantation is a key factor in securing mid-to-long-term stability and ultimately increasing the implant success rate.
[0004] Premature implant failure can occur due to bone loss around the implant or reduced fixation caused by various factors, including product defects, procedural factors, and patient factors. In particular, when bone around the implant is lost, a decrease in the implant's fixation due to this loss is inevitable. Accordingly, an analysis of cases of premature failure due to bone loss around the implant revealed that failures caused by periodontitis or bacterial detection accounted for approximately 90%, and an analysis of products collected from customers revealed the presence of anaerobic bacteria in about 60% of cases.
[0005] To address these issues, a method has been proposed to establish a system capable of actively defending against contaminated saliva and bacteria by imparting antimicrobial properties to the implant surface. In particular, to reduce the early failure rate of implants, the antimicrobial properties must be maintained even during the initial implantation period.
[0006] Meanwhile, in the case of surface treatments currently widely used for implants, such as RBM or SLA, when the product is exposed to air after the treatment process, an oxide layer grows on the surface and various contaminants, including hydrocarbons, are adsorbed, causing the product to become hydrophobic as it transforms into a chemically stable state. Since such a hydrophobic surface has low wettability to bodily fluids and blood, it has the disadvantage of hindering the overall process of bone fusion after implantation, thereby prolonging the implant stabilization period.
[0007] Patent Document 1, a related prior art, describes an implant having a hydrophilic surface after SLA surface treatment. Looking at the manufacturing method described in Patent Document 1, it describes a manufacturing method in which i) the titanium surface is mechanically roughened through various methods, ii) the surface is washed using pure water that may contain additives, and iii) the titanium surface is packaged in a container with an inert atmosphere without additional processes. It further describes that the wettability of the titanium surface maintains a hydrophilic surface exhibiting a contact angle of 20 to 50° with respect to water. Additionally, it mentions water containing salt as a method for maintaining an inert atmosphere, and regarding the salt concentration, it describes a concentration range of 100 to 200 meq / l for monovalent salts such as Na and K, and 1 to 20 meq / l for divalent salts such as Mg and Ca.
[0008] However, in the case of Patent Document 1, a method of cleaning the titanium surface using pure water was applied, but when such a wet method, such as an ultrasonic method, is applied for surface cleaning, there is a disadvantage that it is difficult to remove fine surface contaminants of 1㎛ or less present on the surface, and it is also difficult to clean fine irregular parts that the ultrasound cannot reach.
[0009] As a method for determining the degree of cleaning, "Handbook of Physical Vapor Deposition (PVD) Processing, Donald M. Mattox, Noyes Publications (1998)" states that the degree of cleaning of a surface can be determined by measuring the contact angle, and that surfaces with a contact angle of 20° or more with ultrapure water are presumed to have remaining contamination, and that when a clean surface is formed through an efficient method, it has a contact angle close to 5°.
[0010] In addition, Patent Document 1 applies a method of storing in an aqueous solution containing salt to maintain the hydrophilicity of the surface. However, regarding the concentration of the salt applied, a concentration of 100 to 200 meq / l is sufficient for monovalent salts, whereas a concentration of 1 to 20 meq / l for divalent salts is too low, so there is a problem that the amount is too small to sufficiently cover the entire surface of the fixture when applied to an actual dental implant fixture.
[0011] In addition, Patent Document 2, a related prior art, describes that in order to overcome the hydrophilicity limitations of the technology according to Patent Document 1, a superhydrophilic surface with a contact angle of 10° or less can be secured only by forming a nanopore structure of 50 to 100 nm on the titanium surface through chromium sulfate surface treatment, and that in order to maintain the hydrophilicity of the surface even after drying, it must be stored in an aqueous solution containing salt having a total ion concentration of 0.5 mol / l or more, preferably 1 mol / l or more.
[0012] However, obtaining the aforementioned superhydrophilic surface requires undergoing complex processes such as nanopore formation through chromium sulfate surface treatment, and since a high-concentration salt solution is used to maintain the superhydrophilicity of the surface, safety issues, such as the manifestation of toxicity caused by the salt, may arise when an implant fixture is implanted in the human body.
[0013] Therefore, there is a need to develop a method that actively defends against contaminated saliva and bacteria by imparting antimicrobial properties to the implant surface, while simultaneously modifying the hydrophobic surface of the implant into a hydrophilic one through a precise dry surface cleaning method without altering the inherent physical shape of the implant surface, and maintaining this state for an extended period. Prior art literature
[65535] Prior Art Document 1: Chinese Patent Publication No. 103877618 (June 25, 2014) Prior Art Document 2: Registered Patent Publication No. 10-1972122 (April 24, 2019) Prior Art Document 3: LAURA A. ARDILARODRIGUEZ et al. “The influence of grit blasting and UV / Ozone treatments on Ti-Ti adhesive bonds and their durability after sol-gel and primer application”, INTERNATIONAL JOURNAL OF ADHESION AND ADHESIVES, VOL. 104, pp. 110, 2020. The problem to be solved
[0014] The present invention is intended to solve the problems revealed in the aforementioned prior art, and one of the various objectives of the present invention is to provide a method for manufacturing a dental implant with excellent osseointegration and antibacterial properties and a dental implant manufactured through the same. means of solving the problem
[0015] According to one aspect, a method for manufacturing a dental implant is disclosed, comprising: (a) a step of supporting a titanium substrate in a first solution in which a silver precursor is dissolved and the Ag concentration is 10 to 300 mM; (b) a step of heating the first solution to form a silver-titanium oxide matrix on at least a portion of the surface of the hydrothermally treated titanium substrate; and (c) a step of UV-ozone treating the surface of the titanium substrate on which the silver-titanium oxide matrix is formed to modify it into a superhydrophilic surface having a surface contact angle of 5° or less.
[0016] In one embodiment, the method for manufacturing the dental implant may further include a step of pre-treating the titanium substrate by at least one of sandblasting, etching, washing, and drying before step (a).
[0017] In one embodiment, the silver precursor of the first solution may be one selected from the group consisting of silver nitrate (AgNO3), silver perchlorate (AgClO4), silver tetrafluoroborate (AgBF4), silver hexafluorophosphate (AgPF6), silver acetate (CH3COOAg), silver trifluoromethanesulfonate (AgCF3SO3), silver sulfate (Ag2SO4), silver 2,4-pentanedianate (CH3COCH=COCH3Ag), silver(I) oxide (Ag2O), silver(II) oxide (AgO), silver peroxide (Ag2O2), silver(III) oxide (Ag2O3), and combinations thereof.
[0018] In one embodiment, step (b) may be performed under conditions of 150 to 300°C and 1 to 5 hours.
[0019] In one embodiment, the method for manufacturing the dental implant may further include, after step (b), a step of post-treating the titanium substrate on which the coating layer is formed using one or more methods selected from the group consisting of ethanol immersion and ultrasonic cleaning.
[0020] In one embodiment, the wavelength range of UV for the UV-ozone treatment of step (c) may be 150 to 254 nm.
[0021] In one embodiment, the UV flux density of step (c) may be 20 mW / cm² to 1.0 W / cm².
[0022] In one embodiment, the UV flux density of step (c) may be 45 mW / cm² to 0.2 W / cm².
[0023] In one embodiment, the temperature inside the reaction chamber for the UV-ozone treatment of step (c) may be 10 to 80°C.
[0024] In one embodiment, the UV treatment time for the UV-ozone treatment of step (c) may be 1 minute to 1 hour.
[0025] In one embodiment, the divalent metal salt is Mg 2+ , Ca 2+ , Sr 2+ , Mn 2+ and Zn 2+ It may include one or more divalent metal ions selected from the group consisting of
[0026] In one embodiment, the concentration of the divalent metal ion may be 0.01 mol / L to 0.5 mol / L.
[0027] In one embodiment, (d) a step of immersing at least a portion of the titanium substrate modified to the superhydrophilic surface in a second solution containing a divalent metal salt; may be further included.
[0028] According to another aspect, a dental implant is disclosed in which the surface of a titanium substrate having a silver-titanium oxide matrix formed thereon is modified into a superhydrophilic surface having a surface contact angle of 5° or less by UV-ozone treatment.
[0029] The above silver-titanium oxide matrix has a peak P1 with a binding energy of 570–580 eV and a peak P2 with a binding energy of 360–375 eV as measured by XPS, and the intensity I1 of P1 and the intensity I2 of P2 can satisfy the following equation.
[0030] [ceremony]
[0031] 2*I1≤ I2≤ 5*I1.
[0032] In one embodiment, the dental implant can release less than 1 ppm / day of silver for at least one week in an inorganic solvent at 37°C. Effects of the invention
[0033] According to one aspect of the present invention, a silver-titanium oxide matrix is formed on the surface of an implant to improve the antibacterial properties of the implant. In particular, silver ions from the silver-titanium oxide matrix are released slowly during the initial implantation period, thereby imparting and maintaining the antibacterial properties of the implant. Accordingly, the early failure rate of dental implants can be reduced, and ultimately, the success rate of the implant can be improved.
[0034] In addition, according to one aspect of the present invention, the surface of a dental implant can be modified to be superhydrophilic without undergoing a complex process, allowing for long-term storage, and the bioactivity and blood affinity of the implant surface can be increased to improve the initial osseointegration ability of the implant and shorten the procedure period.
[0035] The effects of one aspect of the present invention are not limited to the effects described above, and should be understood to include all effects that can be inferred from the configurations described in the detailed description of the invention or the claims of this specification. Brief explanation of the drawing
[0036] Figure 1 is an antimicrobial performance evaluation graph for the selection of antimicrobial ions according to the present specification. Figure 2 is a graph of torsional removal force for selecting a method for forming a silver-titanium oxide matrix. Figure 3 is a graph of antibacterial performance evaluation according to hydrothermal treatment conditions. Figure 4 is the result of an FE-SEM analysis image of a titanium substrate with a silver-titanium oxide matrix formed thereon. Figure 5 is an analysis of the elemental distribution of titanium and silver by location in the SEM image of Figure 4. Figure 6 is an EDS analysis image of a titanium substrate with a silver-titanium oxide matrix formed thereon. Figure 7 is an XPS analysis graph of a titanium substrate with a silver-titanium oxide matrix formed thereon. Figure 8 is a photograph showing the change in surface contact angle due to UV-ozone treatment and loading with calcium chloride aqueous solution. Figure 9 is a 100 μm scale FE-SEM image of Example 1. Figure 10 is a 1 μm scale FE-SEM image of Example 1. Figure 11 is a 100 nm scale FE-SEM image of Example 1. Figure 12 shows the results of measuring the saliva contamination inhibition rate for specimens of Examples and Comparative Examples 1 to 3. Figure 13 shows the results of measuring the bone interface bonding strength for specimens of Examples and Comparative Examples 1 to 3. Specific details for implementing the invention
[0037] Hereinafter, one aspect of the present specification will be described with reference to the attached drawings. However, the details described in the present specification may be implemented in various different forms and are therefore not limited to the embodiments described herein.
[0038] Throughout the specification, when it is stated that a part is "connected" to another part, this includes not only cases where they are "directly connected," but also cases where they are "indirectly connected" with other members interposed between them. Furthermore, when it is stated that a part "includes" a certain component, this means that, unless specifically stated otherwise, it does not exclude other components but rather allows for the inclusion of additional components.
[0039] When a range of numerical values is described in this specification, unless a specific range is otherwise described, the value has the precision of significant figures provided according to the standard rules in chemistry for significant figures. For example, 10 includes a range of 5.0 to 14.9, and the number 10.0 includes a range of 9.50 to 10.49.
[0040] A method for manufacturing a dental implant, which is one aspect of the present invention, will be described in detail below.
[0041] Method for manufacturing dental implants
[0042] A method for manufacturing an implant, which is one aspect of the present invention, comprises: (a) a step of supporting a titanium substrate in a first solution in which a silver precursor is dissolved and the Ag concentration is 10 to 300 mM; (b) a step of heating the first solution to form a silver-titanium oxide matrix on at least a portion of the surface of the hydrothermally treated titanium substrate; and (c) a step of UV-ozone treating the surface of the titanium substrate on which the silver-titanium oxide matrix is formed to modify it into a superhydrophilic surface having a surface contact angle of 5° or less.
[0043] (a) Step
[0044] Step (a) above may involve supporting a titanium substrate in a first solution in which a silver precursor is dissolved. The silver precursor included in the first solution may be, for example, one or more selected from the group consisting of silver nitrate (AgNO3), silver perchlorate (AgClO4), silver tetrafluoroborate (AgBF4), silver hexafluorophosphate (AgPF6), silver acetate (CH3COOAg), silver trifluoromethanesulfonate (AgCF3SO3), silver sulfate (Ag2SO4), silver 2,4-pentanedione (CH3COCH=COCH3Ag) and silver oxides (AgO, Ag2O, Ag2O2, Ag2O3), but is not limited thereto.
[0045] The Ag concentration of the first solution above may be 10 to 300 mM. For example, 10mM, 11mM, 12mM, 13mM, 14mM, 15mM, 16mM, 17mM, 18mM, 19mM, 20mM, 21mM, 22mM, 23mM, 24mM, 25mM, 26mM, 27mM, 28mM, 29mM, 30mM, 31mM, 32mM, 33mM, 34mM, 35mM, 36mM, 37mM, 38mM, 39mM, 40mM, 41mM, 42mM, 43mM, 44mM, 45mM, 46mM, 47mM, 48mM, 49mM, 50mM, 51mM, 52mM, 53mM, 54mM, 55mM, 56mM, 57mM, 58mM, 59mM, 60mM, 61mM, 62mM, 63mM, 64mM, 65mM, 66mM, 67mM, 68mM, 69mM, 70mM, 71mM, 72mM, 73mM, 74mM, 75mM, 76mM, 77mM, 78mM, 79mM, 80mM, 81mM, 82mM, 83mM, 84mM, 85mM, 86mM, 87mM, 88mM, 89mM, 90mM, 91mM, 92mM, 93mM, 94mM, 95mM, 96mM, 97mM, 98mM, 99mM, 100mM, 110mM, 120mM, 130mM, 140mM, 150mM, 160mM, 170mM, 180mM, 190mM, 200mM, 210mM, 220mM, 230mM, 240mM, 250mM, 260mM, 270mM, 280mM, 290mM, 300mM, or a value between two of these values, but is not limited thereto. If the Ag concentration is below the above range, the amount of silver is insufficient, which may reduce antibacterial properties, and if it exceeds the above range, it may be difficult to form the coating solution or the formation of the coating layer may be poor due to problems such as viscosity.
[0046] Before performing step (a) above, a pretreatment step of treating the titanium substrate by at least one of sandblasting, etching, washing, and drying may be further included, but is not limited thereto.
[0047] When surface roughness is imparted to the titanium substrate by sandblasting or etching, bone fusion characteristics may be improved, but adhesion to bacteria may also be increased. Foreign substances on the surface of the titanium substrate can be removed by washing or drying the titanium substrate, and a subsequent antibacterial coating layer can be effectively formed.
[0048] (b) Step
[0049] Step (b) above is a step of heating the coating solution to form a silver-titanium oxide matrix on the surface of the hydrothermally treated titanium substrate, and can be performed under conditions of 150 to 300°C and 1 to 5 hours.
[0050] The above step (b) may be performed, for example, at 150℃, 155℃, 160℃, 165℃, 170℃, 175℃, 180℃, 185℃, 190℃, 195℃, 200℃, 205℃, 210℃, 215℃, 220℃, 225℃, 230℃, 235℃, 240℃, 245℃, 250℃, 255℃, 260℃, 265℃, 270℃, 275℃, 280℃, 285℃, 290℃, 295℃, 300℃, or at a value between two of these values, but is not limited thereto. The temperature conditions of step (b) above may affect the amount of silver coating on the silver-titanium oxide matrix and the resulting antibacterial performance.
[0051] Additionally, the above step (b) may be performed for, for example, 1 hour, 1.5 hours, 2 hours, 2.5 hours, 3 hours, 3.5 hours, 4 hours, 4.5 hours, 5 hours, or a time between two of these values, but is not limited thereto.
[0052] After step (b) above, the surface of the titanium substrate may be washed to remove unbonded silver ions. However, such washing may be performed in a manner that does not impair the antibacterial performance of the silver-titanium oxide matrix formed on the surface of the titanium substrate. For example, it may be performed by immersing in one selected from the group consisting of purified water, alcohol, and mixtures thereof, and then stirring.
[0053] (c) Step
[0054] Step (c) above is a step of modifying the surface of a titanium substrate having a silver-titanium oxide matrix formed thereon into a superhydrophilic surface having a surface contact angle of 5° or less by performing UV-ozone treatment.
[0055] To increase the success rate of dental implants, a stable bond must be formed with the user's surrounding bone during the initial implantation period. For this osseointegration process to proceed stably, the implant must have a large surface area and exhibit hydrophilicity. In particular, the surface area can be enhanced by creating micro-scale roughness on the implant surface, and such micro-scale roughness can be formed by various methods, including particle spraying, absorbent spray medium, acid etching, alkali etching, titanium plasma spraying, acid treatment after particle spraying, anodic oxidation, and laser surface processing.
[0056] Implants with such micro-scale roughness have the advantage of improving osseointegration by increasing their surface area, but they have the disadvantage that contamination from various airborne contaminants increases during storage before implant surgery due to the large surface area. In particular, carbon contaminants present in the air are irreversibly adsorbed onto the surface of the implant, making the implant surface hydrophobic. When the implant surface becomes hydrophobic, various blood proteins cannot adhere to the implant surface when the implant is implanted in the body. Consequently, the biocompatibility of the implant surface decreases, making osseointegration difficult. Furthermore, inflammatory reactions caused by contaminants may be induced, or problems such as implant failure may occur.
[0057] However, in the present invention, the surface of an implant that is hydrophobic, having a surface contact angle of 50° or more, is modified into a superhydrophilic surface having a surface contact angle of 5° or less by UV-ozone treatment, thereby having excellent affinity for body fluids and blood after the procedure, resulting in superior bone formation effects and a shortened bone fusion period.
[0058] In addition, unlike conventional cleaning methods, the present invention provides a cleaning method that decomposes the micro-contamination layer on the surface by the reaction of ionized components in a vacuum or atmosphere without using a solvent, and since it does not alter the physical shape of the implant surface, the surface contact angle can be changed to superhydrophilicity of 5° or less with a simple process. The implant modified to be superhydrophilic according to the present invention exhibits excellent affinity for body fluids and blood after the procedure, resulting in superior bone formation effects and a shortened bone fusion period.
[0059] Step (c) above can be performed in a UV flux density range of 20 mW / cm² to 1.0 W / cm² so as to remove surface contamination of 1 µm or less present in fine uneven areas. More preferably, the UV flux density may be 45 mW / cm² to 0.2 W / cm². For example, 20mW / ㎠, 25mW / ㎠, 30mW / ㎠, 40mW / ㎠, 45mW / ㎠, 50mW / ㎠, 55mW / ㎠, 60mW / ㎠, 65mW / ㎠, 70mW / ㎠, 75mW / ㎠, 80mW / ㎠, 85mW / ㎠, 90mW / ㎠, 95mW / ㎠, 0.1W / ㎠, 0.11W / ㎠, 0.12W / ㎠, 0.13W / ㎠, 0.14W / ㎠, 0.15W / ㎠, 0.16W / ㎠. It may be 0.17 W / ㎠, 0.18 W / ㎠, 0.19 W / ㎠, 0.2 W / ㎠, 0.3 W / ㎠, 0.4 W / ㎠, 0.5 W / ㎠, 0.6 W / ㎠, 0.7 W / ㎠, 0.8 W / ㎠, 0.9 W / ㎠, 1.0 W / ㎠, or a value between two of these values, but is not limited thereto.
[0060] Preferably, in step (c) above, the UV wavelength range for UV-ozone treatment may be in the range of 150 to 254 nm, where ozone generation due to UV is most active. For example, it may be 150 nm, 155 nm, 160 nm, 165 nm, 170 nm, 175 nm, 180 nm, 185 nm, 190 nm, 195 nm, 200 nm, 205 nm, 210 nm, 215 nm, 220 nm, 225 nm, 230 nm, 235 nm, 240 nm, 245 nm, 250 nm, 254 nm, or a value between two of these values, but is not limited thereto.
[0061] The temperature inside the reaction chamber where UV-ozone treatment is performed in step (c) above may be 10 to 80°C. For example, it may be 10°C, 15°C, 20°C, 25°C, 30°C, 35°C, 40°C, 45°C, 50°C, 55°C, 60°C, 65°C, 70°C, 75°C, 80°C, or a value between two of these values. If the temperature inside the reaction chamber satisfies the above range, it may be advantageous to induce sufficient surface modification, but it is not limited thereto.
[0062] The UV treatment time for the UV-ozone treatment in step (c) above may be 1 minute to 1 hour. For example, it may be 1 minute, 2 minutes, 3 minutes, 4 minutes, 5 minutes, 10 minutes, 15 minutes, 20 minutes, 25 minutes, 30 minutes, 35 minutes, 40 minutes, 45 minutes, 50 minutes, 55 minutes, 56 minutes, 57 minutes, 58 minutes, 59 minutes, 1 hour, or a value between two of these values. If the UV treatment time satisfies the above range, it may be advantageous to cause sufficient surface modification, but it is not limited thereto.
[0063] Through step (c) above, the surface of the silver-titanium oxide matrix can have a surface contact angle of 5° or less. Through this, it is possible to realize an implant with excellent bone formation effects due to its excellent affinity for body fluids and blood after the procedure.
[0064] The method for manufacturing the above implant may further include the step of (d) immersing at least a portion of the titanium substrate modified with the superhydrophilic surface in a second solution containing a divalent metal salt.
[0065] (d) Step
[0066] Step (d) above is characterized by immersing at least a portion of the titanium substrate modified into the superhydrophilic surface in a second solution containing a divalent metal salt so that the modified surface does not become hydrophobic even after drying and can maintain a hydrophilicity of at least 20° or less.
[0067] The divalent metal salt included in the second solution above is Mg 2+ , Ca 2+ , Sr 2+ , Mn 2+ and Zn 2+ It is preferable to include at least one divalent metal ion from the group consisting of, and more preferably Ca 2+ It is better to use .
[0068] In order for the surface of the implant to maintain hydrophilicity while the implant is left in the atmosphere after the above step (d) is completed, the contact angle must be maintained at less than 20°. Therefore, it is preferable that the concentration of the divalent metal ion in the second solution containing the divalent metal salt be 0.01 mol / L to 0.5 mol / L, but is not limited thereto. For example, the concentration of the solution containing the divalent metal salt may be 0.01 mol / L, 0.05 mol / L, 0.1 mol / L, 0.15 mol / L, 0.2 mol / L, 0.25 mol / L, 0.3 mol / L, 0.35 mol / L, 0.4 mol / L, 0.45 mol / L, 0.5 mol / L, or a value between two of these values. If the concentration of the solution containing the divalent metal salt exceeds the above range, it may kill oral cells due to toxicity, and if it is below the above range, the divalent metal salt solution may not be able to sufficiently cover the implant surface, leading to carbon contamination in the atmosphere.
[0069] Dental implants
[0070] A dental implant according to another aspect of the present invention comprises a titanium substrate and a silver-titanium oxide matrix formed on at least a portion of the surface of the titanium substrate.
[0071] The above dental implant may be a titanium substrate having a silver-titanium oxide matrix formed on its surface that has been modified into a superhydrophilic surface having a surface contact angle of 5° or less by UV-ozone treatment.
[0072] The above dental implant can release silver at a rate of 1 ppm / day or less for at least one week in an inorganic solvent at 37°C. The sustained-release effect of the above dental implant can last for at least one week, one month, two months, three months, or longer. The sustained-release effect of the above dental implant may mean achieving a continuous antibacterial effect by releasing at least one of silver ions and silver metal for a long period. The above inorganic solvent may refer to water, such as purified water or ion-exchanged water. The above dental implant can release silver at a rate of at least 1 ppb / day, 5 ppb / day, or 10 ppb / day during the above period.
[0073] Titanium substrate
[0074] The above titanium material refers to a material composed of pure titanium or an alloy of titanium and other metals on the periodic table. The above titanium alloy may be, for example, one selected from the group consisting of titanium (Ti), aluminum (Al), silicon (Si), vanadium (V), niobium (Nb), zirconium (Zr), molybdenum (Mo), chromium (Cr), tin (Sn), tantalum (Ta), palladium (Pd), and combinations of at least one of these, but is not limited thereto.
[0075] Silver-titanium oxide matrix
[0076] To increase the success rate of dental implants, a stable bond must be formed with the user's surrounding bone during the initial implantation period. Among the various factors contributing to implantation failure, early failure due to bacterial infection accounts for a significant proportion.
[0077] The dental implant of the present invention comprises a silver-titanium oxide matrix formed on at least a portion of a titanium substrate, and the silver-titanium oxide matrix has a peak P1 with a binding energy of 570 to 580 eV and a peak P2 with a binding energy of 360 to 375 eV as measured by XPS, and the intensity I1 of P1 and the intensity I2 of P2 satisfy the following equation, thereby exhibiting excellent antibacterial properties.
[0078] [ceremony]
[0079] 2*I1≤ I2≤ 5*I1.
[0080] The silver-titanium oxide matrix can block quorum sensing to suppress the formation of a biofilm on the surface of the implant. Accordingly, the early failure rate of the implant can be reduced, the peeling of the implant coating film can be prevented, and ultimately, the success rate of the implant can be improved.
[0081] Here, the term “quorum sensing” refers to a bacterial density-dependent gene expression regulation mechanism in which the collective metabolic activity of bacteria is regulated when a specific concentration is reached, as it accumulates in proportion to cell density during bacterial proliferation. In other words, it refers to a phenomenon in which, when the bacterial cell concentration reaches the so-called quorum for decision-making due to proliferation, specific traits not observed in low-density cells are collectively induced and expressed. In particular, pathogenic bacteria can cause infection by inducing virulence through quorum sensing.
[0082] The silver-titanium oxide matrix can kill bacteria by releasing silver ions, which are antimicrobial ions. As a result, it can inhibit the attachment of bacteria to the surface of the implant. The silver ions can bind to the cysteine groups of the bacterial membrane to inactivate proteins and induce the release of reactive oxygen species from the bound cells, thereby killing the bacteria. By killing bacteria through the aforementioned mechanism, the silver ions can effectively inhibit the formation of biofilms and maintain antimicrobial properties continuously without antimicrobial resistance.
[0083] The above silver-titanium oxide matrix may contain antimicrobial components in various forms. As a result, it may have the level of antimicrobial activity required during the initial implantation stage and may be able to sustain an antimicrobial effect for a long period.
[0084] Peaks P1 and I1 with binding energies of 570–580 eV may represent the range and intensity value of the Ag 2p peak. Peaks P2 and I2 with 360–375 eV may represent the range and intensity value of the Ag 3d peak. The Ag 2p may represent silver metal, and Ag 3d may represent oxidized silver ions. A silver-titanium oxide matrix in which the intensities I1 and I2 at these peaks satisfy specific conditions can simultaneously contain silver metal and silver ions to achieve a sustained-release effect. Furthermore, if I1 and I2 satisfy specific conditions, the success rate of early implantation of the dental implant can be effectively increased.
[0085] The conditions of I1 and I2 expressed by the above formula may refer to the ratio between silver metal and silver ions measured in the XPS graph. The above I2 may be 2 times or more and 5 times or less of I1. In one example, the above I2 may be 2 times or more, 2.1 times or more, 2.2 times or more, 2.3 times or more, 2.4 times or more, 2.5 times or more, 2.6 times or more, 2.7 times or more, 2.8 times or more, 2.9 times or more, 3 times or more, 3.1 times or more, 3.2 times or more, 3.3 times or more, or 3.4 times or more of I1. In another example, the above I2 may be 5 times or less, 4.9 times or less, 4.8 times or less, 4.7 times or less, 4.6 times or less, 4.5 times or less, 4.4 times or less, 4.3 times or less, 4.2 times or less, 4.1 times or less, 4 times or less, 3.9 times or less, 3.8 times or less, 3.7 times or less, or 3.6 times or less of I1.
[0086] Dental implants satisfying the above conditions have a high initial silver release rate, which can provide antibacterial effects such as bacterial killing and inhibition of attachment during the initial implantation period. In addition, by having a sustained-release effect in which silver is released slowly, the antibacterial effect can be continuously maintained.
[0087] The embodiments of this specification will be described in more detail below. However, the following experimental results represent only representative results among the above embodiments, and the scope and content of this specification should not be interpreted as being narrowed or limited by the embodiments. The respective effects of various embodiments of this specification not explicitly presented below will be described in detail in the relevant sections.
[0088] Experimental Example 1: Selection of Antimicrobial Ions
[0089] To select antimicrobial ions, the salivary bacterial contamination rate was evaluated. Saliva (saliva, SA) was prepared as the control group, and 100 ml each of physiological saline (Saline), hydrated solution (EC), magnesium ion salt, and silver ion salt were prepared as the experimental group. 1 ml of the salivary bacterial suspension isolated from the prepared saliva was added to each of the control and experimental group solutions, and the mixtures were maintained at 37°C under anaerobic conditions for 16 hours. After 16 hours, the salivary bacterial contamination rate was measured, and the results are shown in Figure 1. The salivary bacterial contamination rate of the control group saliva was set to 100%, and the salivary bacterial contamination rate of the experimental group was measured.
[0090] Referring to Figure 1, physiological saline and hydrated solution (EC) showed salivary bacterial contamination rates of 52.45% and 23.6%, respectively, compared to saliva. Magnesium ion salt, an antimicrobial ion salt, showed the highest salivary bacterial contamination rate at 102.34%. In contrast, silver ion salt showed a salivary bacterial contamination rate of 0.28%, representing a 99.7% reduction in bacterial contamination compared to saliva. Therefore, silver ions were selected as the antimicrobial ion.
[0091] Experimental Example 2: Selection of Silver-Titanium Oxide Matrix
[0092] (1) Selection of method for forming silver-titanium oxide matrix
[0093] Animal experiments were conducted to select a method for forming a silver-titanium oxide matrix. Titanium implants were prepared as a control group. For the experimental group, titanium implants treated with a solution containing silver ion salts and hydrogen peroxide, and titanium implants hydrothermally treated (HT) with a solution containing silver ion salts were prepared. Eight samples of each implant were prepared. The prepared implants were contaminated by immersing them in saliva for 24 hours prior to implantation, and then implanted into the tibia of rabbits. After maintaining the implants for 21 days to allow for bone formation, the removal torque was evaluated. The experimental results are shown in Figure 2.
[0094] Figure 2(a) shows the average torsional removal force for each of the eight samples. Figure 2(b) shows the torsional removal force for each of the eight samples. The untreated titanium implant showed the worst performance with an average torsional removal force of 26.95 N, recording 2 implantation failures out of 8 cases. In contrast, the silver ion-coated implants showed values of 46.43 N and 52.11 N, respectively, confirming that salivary contamination by silver ions is reduced. Furthermore, the implant coated with silver ions via hydrothermal treatment exhibited the best torsional removal force, recording 0 implantation failures out of 8 cases. Therefore, the excellent antibacterial properties of silver ions against salivary bacteria were confirmed, and the hydrothermal treatment method was selected as the coating method.
[0095] (2) Selection of Sequence Treatment Conditions 1
[0096] To select hydrothermal treatment conditions, an evaluation of antibacterial performance was performed according to temperature, time, and silver ion concentration.
[0097] Titanium substrate 3 x 3 cm for evaluation 2 Nine samples of the size were prepared. For the hydrothermal treatment conditions of each titanium substrate, the temperature was set to 180℃, 200℃, and 250℃, the time was set to 1 hour, 2 hours, and 3 hours, and the silver ion concentration was set to 30 mM, 60 mM, and 100 mM.
[0098] Aggregatilacter actinomycetemcomitans ATCC 33384 and Porphyromonas gingivalis, which are causative agents of acute periodontitis or peri-implantitis, were used as salivary bacteria. The prepared salivary bacteria were each inoculated into BHI (Brain heart infusion broth, Merck) medium and cultured for 16 to 24 hours under anaerobic conditions at 37°C. The culture solution was diluted in BHI medium until the absorbance at 600 nm was 0.1, and then further diluted once in BHI medium to reduce the bacterial concentration to 1 / 10 to prepare two types of salivary bacterial suspensions.
[0099] The above nine titanium substrates were sterilized by exposing them to UV light in a clean bench for 30 minutes, and then one was placed in each well of a 24-well plate. 1 mL of the prepared salivary bacterial suspension was added to each well and incubated for 16 hours at 37°C under anaerobic conditions. 1 mL of a 0.1 wt% crystal violet solution was added to each well of a new 24-well plate. The samples were transferred to each well of the plate containing crystal violet and incubated at room temperature for 10 minutes to stain the bacteria purple.
[0100] A new 24-well plate was prepared by adding 1 mL of phosphate buffered saline (PBS) solution to each well, and each stained sample was transferred to each well, after which the above process was repeated once more. The samples washed with PBS solution were transferred onto a dry tissue to wipe the bottom surface of the samples. 500 μL of a 30 wt% acetic acid solution was added to each well of a new 24-well plate, and each sample was transferred to each well. The plates were then incubated at room temperature for 20 minutes to dissolve the stain. 200 μL of the dissolved solution was added to a 96-well plate, and the absorbance (595 nm) was measured using a microplate reader, and the results are shown in Figure 3. For comparison with the samples, the absorbance (OD, 595 nm) of a control group treated with a salivary bacteria suspension as described above was also measured, along with a medium (Media) not inoculated with salivary bacteria and an untreated titanium substrate sample.
[0101] The sequence processing conditions for each of the 9 samples are shown in Table 1 below.
[0102] division Temperature (°C) Time (h) Silver ion concentration (mM) Absorbance (595 nm) Sample 1 180 1 30 0.244 Sample 2 180 2 60 0.078 Sample 3 180 3 100 0.071 Sample 4 200 1 60 0.115 Sample 5 200 2 100 0.061 Sample 6 200 3 30 0.070 Sample 7 250 1 100 0.071 Sample 8 250 2 30 0.071 Sample 9 250 3 60 0.070
[0103] Referring to Table 1 and Figure 3, all samples except samples 1 and 4 showed an OD (595 nm) value of 0.08 or less, confirming that the inhibitory effect of silver ions on salivary bacteria is excellent.
[0104] To derive the optimal hydrothermal treatment conditions, the OD (595 nm) values according to temperature, time, and silver ion concentration were summed and shown in Table 2.
[0105] division condition Absorbance (595 nm) Difference (maximum value - minimum value) Temperature (°C) 180 0.393 0.181 200 0.246 250 0.212 Time (h) 1 0.430 0.22 2 0.210 3 0.211 Silver ion concentration (mM) 30 0.385 0.182 60 0.263 100 0.203
[0106] Referring to Table 2, the OD (595 nm) values according to temperature conditions in hydrothermal treatment were 0.246 and 0.212 at 200°C and 250°C, respectively, confirming that antibacterial activity was improved compared to hydrothermal treatment at 180°C. In addition, the salivary bacterial contamination rate according to time conditions was excellent at 2 and 3 hours, and the salivary bacterial contamination rate according to silver ion concentration was excellent at 60 mM and 100 mM. Therefore, the optimal hydrothermal treatment conditions for improving antibacterial activity were determined to be a temperature of 200–250°C, a time of 2–3 hours, and a silver ion concentration of 60–100 mM.
[0107] (3) Selection of Sequence Treatment Conditions 2
[0108] To select hydrothermal treatment conditions, the inhibition rate of salivary bacterial contamination, initial titanium (Ti) ion elution amount, and silver (Ag) ion release amount were evaluated according to H2O2 concentration (chemical treatment), temperature, and time during hydrothermal treatment.
[0109] Titanium substrate 3 x 3 cm for evaluation 2 Nine samples of the size were prepared. For the hydrothermal treatment conditions of each titanium substrate, the H2O2 concentration was set to 0 wt% (no addition), 1 wt%, and 2 wt%, the temperature was set to 180℃, 200℃, and 250℃, the time was set to 1 hour, 2 hours, and 3 hours, and the silver ion concentration was fixed at 100 mM.
[0110] The salivary bacteria contamination inhibition rate was conducted in the same manner as the antibacterial performance evaluation described in Experimental Example 3, and the salivary bacteria contamination inhibition rate was derived based on the OD (595 nm) value of an untreated titanium substrate sample contaminated with salivary bacteria.
[0111] Inhibition rate of salivary bacterial contamination (%) = (Absorbance measurement of antimicrobial coated sample according to hydrothermal treatment conditions) / (Absorbance measurement of untreated sample)
[0112] To derive the optimal hydrothermal treatment conditions, the sum of the salivary bacterial contamination inhibition rate, initial Ti leaching amount, and Ag release amount according to H2O2 concentration, temperature, and time, respectively, is shown in Table 3.
[0113] division condition Salivary bacterial contamination inhibition rate (%) Ag emission amount (ppb) Initial Ti leaching amount (ppb) sum value Difference (maximum value - minimum value) sum value Difference (maximum value - minimum value) sum value Difference (maximum value - minimum value) H2O2 concentration 0% 2.89 0.08 1517.42 772.7 10.32 668.03 1% 2.96 1774.65 178.16 2% 2.97 2290.12 678.35 temperature 150℃ 2.93 0.04 947.67 2323.8 689.47 658.26 200℃ 2.93 3271.52 31.21 250℃ 2.97 1363 146.15 hour 1h 2.92 0.06 1675.6 463.3 179.19 394.58 2h 2.93 2138.9 541.11 3h 2.98 1767.69 146.53
[0114] Referring to Table 3, regarding the inhibition rate of salivary bacterial contamination under hydrothermal treatment conditions according to H2O2 concentration, the difference between the maximum and minimum values was 0.08, indicating a minor difference; however, it was confirmed that the initial Ti leaching amount increased significantly as the concentration increased. Accordingly, it was decided not to use H2O2 during hydrothermal treatment. Furthermore, regarding temperature conditions, significant results were obtained at temperatures above 200℃, where the release of Ag ions was excellent and the initial Ti ion leaching was low. Regarding the inhibition rate of salivary bacterial contamination under time conditions, the highest inhibition rate was observed at 3 hours; the release of Ag ions was highest at 2 hours; and the initial Ti ion leaching amount was lowest at 3 hours.
[0115] (4) FE-SEM and EDS analysis of silver-titanium oxide matrix
[0116] Based on the results of the selection of the antimicrobial ions described above and the results of the selection of the method and conditions for forming the silver-titanium oxide matrix, a titanium substrate (Preparation Example 1) having a silver-titanium oxide matrix formed thereon was prepared.
[0117] Specifically, a disc (cylindrical) Cp-Ti (Titanium Grade 4) specimen with a diameter of 6 mm, a thickness of 2 mm, and a length of 10 mm was prepared. The specimen was immersed in a silver nitrate solution with an Ag concentration of 100 mM and then heated to perform hydrothermal treatment at a temperature of 200°C for 3 hours. After hydrothermal treatment, the specimen was immersed in deionized water for 5 minutes and washed to produce a titanium substrate (Preparation Example 1) with a silver-titanium oxide matrix formed on its surface.
[0118] Subsequently, FE-SEM and EDS analysis were performed to analyze the surface of Preparation Example 1, and the results are shown in FIGS. 4 to 6.
[0119] Figure 4 is the result of the FE-SEM analysis image of Preparation Example 1. Referring to Figure 4, it can be confirmed that silver particles were formed on the surface of Preparation Example 1.
[0120] Figure 5 analyzes the elemental distribution of titanium and silver by location in the SEM image of Figure 4. Referring to Figure 5, at location 1, titanium was 99.79 at% and silver was 0.21 at%, at location 2, titanium was 99.69 at% and silver was 0.31 at%, and at location 3, titanium was 94.16 at% and silver was 5.84 at%. It can be confirmed that the at% of silver increased at location 3 due to the formation of bulk silver particles.
[0121] Figure 6 is an EDS analysis image of Preparation Example 1. Referring to Figure 6, it can be seen that silver is evenly distributed on the surface of the titanium substrate in Preparation Example 1.
[0122] (5) XPS analysis of silver-titanium oxide matrix
[0123] XPS analysis was performed to analyze the atomic state of the silver-titanium oxide matrix, and the results are shown in Figure 7. An untreated Cp-Ti (Titanium Grade 4) specimen was also subjected to XPS analysis as a control.
[0124] Referring to Fig. 7, it can be seen that Ag metal (Ag 2p) and oxidized Ag ion (Ag 3d) peaks were simultaneously detected in the analysis graph of the silver-titanium oxide matrix. Accordingly, it can be confirmed that silver particles were effectively coated on the surface of the titanium substrate. In the control group, it can be seen that the oxidized Ti ion peak appeared weakly because no surface treatment was performed.
[0125] When comparing the heights of the Ag metal peak and the oxidized Ag ion peak, it can be seen that the Ag 3d peak at 360–375 eV is about 3.5 times higher than the Ag 2p peak at 570–580 eV.
[0126] Experimental Example 3: Measurement of Surface Contact Angle by UV-Ozone Treatment and Immersion in Calcium Chloride Solution
[0127] Preparation Examples 2 and 3 were prepared to investigate the surface modification effects of UV-ozone treatment and immersion in an aqueous calcium chloride solution. A machined titanium implant or disc was blasted for 1 to 60 seconds at a blasting pressure of 1 to 10 atmospheres using Al2O3 powder with a particle size of 1 mm or less, and then macro and micro morphology was imparted to the surface of the implant or disc using an acid treatment method with a mixed acid aqueous solution. Preparation Example 2 was prepared by ultrasonically cleaning the acid-etched dental titanium implant or disc with ethanol for 30 minutes and with distilled water for 30 minutes, and then drying it.
[0128] The implant or disc that underwent the above SA (Sandblasting and Acid etching) process was treated with UV-ozone for 5 minutes to remove contaminants adsorbed and stabilized on the surface, and then immersed in a 20 mM aqueous calcium chloride (CaCl2) solution for 70 minutes to coat the surface with a divalent salt.
[0129] To confirm the wettability of Preparation Examples 2 and 3 above, 5 ml of distilled water was dropped onto the center of the disc and photographed from the side with a digital camera, and the contact angle between the distilled water and the titanium surface was measured through analysis of the side photograph. At this time, a disc (Preparation Example 2) that was not treated with UV-ozone or immersed in an aqueous calcium chloride solution was used as a negative control.
[0130] As can be seen in Fig. 8, in Preparation Example 3, which was immersed in an aqueous calcium chloride solution after UV irradiation for 5 minutes, the contact angle of the SA disk was lowered from 97 degrees to 0 degrees, forming a hydrophilic surface.
[0131] Examples and Comparative Examples
[0132] <Example 1>
[0133] A disc (cylindrical) Cp-Ti (Titanium Grade 4) specimen with a diameter of 6 mm, a thickness of 2 mm, and a length of 10 mm was prepared. The specimen was immersed in a silver nitrate solution with an Ag concentration of 100 mM and then heated to perform hydrothermal treatment at a temperature of 200°C for 3 hours. After hydrothermal treatment, the specimen was immersed in deionized water for 5 minutes and washed to produce a titanium substrate with a silver-titanium oxide matrix formed on its surface. The prepared titanium specimen was treated with UV-ozone for 5 minutes to remove contaminants adsorbed and stabilized on the surface. Finally, the specimen was immersed in a 20 mM aqueous calcium chloride (CaCl2) solution for 70 minutes to allow a divalent metal salt to be coated on the surface.
[0134] <Comparative Example 1>
[0135] A Cp-Ti (Titanium Grade 4) specimen of the same size and shape as in Example 1 was prepared, and the specimen was processed in the same manner as in Preparation Example 2.
[0136] <Comparative Example 2>
[0137] A Cp-Ti (Titanium Grade 4) specimen of the same size and shape as in Example 1 was prepared, and the specimen was manufactured by processing it in the same way as in Preparation Example 3.
[0138] <Comparative Example 3>
[0139] A Cp-Ti (Titanium Grade 4) specimen of the same size and shape as in Example 1 was prepared, and the specimen was manufactured by processing it in the same way as in Preparation Example 1.
[0140] Experimental Example 4: FE-SEM Analysis of Example 1
[0141] FE-SEM analysis was performed for the surface analysis of Example 1, and the results are shown in Fig. 9.
[0142] FIGS. 9 to 11 are FE-SEM analysis images of Example 1 of the present specification. From FIGS. 9 and 10, it can be confirmed that a calcium coating film was effectively formed, and from FIG. 11, it can be confirmed that silver nanoparticles were coated due to Ag hydrothermal treatment.
[0143] Experimental Example 5: Evaluation of antibacterial performance according to manufacturing method
[0144] To evaluate the antibacterial performance of the examples and comparative examples, the inhibition rate of salivary bacterial contamination of specimens for Example 1 and Comparative Examples 1 to 3 was measured, and the results are shown in Fig. 12. At this time, TSB media (Tryptic Soy Broth) was used as a control.
[0145] As shown in Fig. 12, Comparative Example 3 and Example, in which Ag ions were hydrothermally treated, showed a salivary bacterial contamination inhibition rate of 90% or higher, demonstrating excellent antibacterial performance, whereas Comparative Examples 1 and 2 showed a very low salivary bacterial contamination inhibition rate, indicating that there is a risk of bacterial infection during implant surgery.
[0146] Experimental Example 6: Evaluation of Bone Interfacial Bonding Strength According to Manufacturing Method
[0147] To evaluate the bone interface bonding strength of the examples and comparative examples, an experiment was conducted to verify the bone interface bonding strength of the specimens for Example 1 and Comparative Examples 1 to 3.
[0148] The above implants, with a diameter of 3.5 mm and a length of 8.5 mm, were implanted into the mandible of adult dogs, and after a bone formation period of 21 days, the removal torque was measured for 8 samples.
[0149] As shown in Fig. 13, the torsional removal force of Example 1 was the highest at 83.1 N, and Comparative Examples 1 to 3 showed lower torsional removal forces on average compared to the Example, confirming that the bone interface bonding strength and bone integration of Example 1 are excellent.
[0150] The foregoing description of this specification is for illustrative purposes only, and those skilled in the art to which one aspect of this specification pertains will understand that other specific forms can be easily modified without altering the technical concept or essential features described in this specification. Therefore, the embodiments described above should be understood as illustrative in all respects and not restrictive. For example, each component described as a single unit may be implemented in a distributed manner, and components described as distributed may likewise be implemented in a combined form.
[0151] The scope of this specification is defined by the claims set forth below, and all modifications or variations derived from the meaning and scope of the claims and equivalent concepts thereof should be interpreted as being included within the scope of this specification.
Claims
Claim 1 (a) a step of supporting a titanium substrate in a first solution in which a silver precursor is dissolved and the Ag concentration is 60 to 100 mM; (b) a step of heating the first solution to form a silver-titanium oxide matrix on at least a portion of the surface of the hydrothermally treated titanium substrate; and (c) a step of modifying the surface of a titanium substrate having the silver-titanium oxide matrix formed thereon into a superhydrophilic surface having a surface contact angle of 5° or less by UV-ozone treatment; wherein step (b) is performed under conditions of 200~250℃ and 2~3 hours, and the silver-titanium oxide matrix has a peak P1 with a binding energy of 570~580 eV and a peak P2 with a binding energy of 360~375 eV measured by XPS, and the intensity I1 of P1 and the intensity I2 of P2 satisfy the following formula, wherein the dental implant emits silver of at least 1 ppb / day and at least 1 ppm / day for at least 1 week in an inorganic solvent at 37℃: [Formula] 3.4*I1≤I2≤3.6*I1. Claim 2 A method for manufacturing a dental implant according to claim 1, further comprising, prior to step (a), a step of pre-treating the titanium substrate by at least one of sandblasting, etching, washing, and drying. Claim 3 A method for manufacturing a dental implant according to claim 1, wherein the silver precursor of the first solution is one selected from the group consisting of silver nitrate (AgNO3), silver perchlorate (AgClO4), silver tetrafluoroborate (AgBF4), silver hexafluorophosphate (AgPF6), silver acetate (CH3COOAg), silver trifluoromethanesulfonate (AgCF3SO3), silver sulfate (Ag2SO4), silver 2,4-pentanedianate (CH3COCH=COCH3Ag), silver(I) oxide (Ag2O), silver(II) oxide (AgO), silver peroxide (Ag2O2), silver(III) oxide (Ag2O3), and combinations thereof. Claim 4 delete Claim 5 A method for manufacturing a dental implant according to claim 1, further comprising, after step (b), a step of post-treating the titanium substrate on which the silver-titanium oxide matrix is formed by one or more methods selected from the group consisting of ethanol impregnation and ultrasonic cleaning. Claim 6 A method for manufacturing a dental implant according to claim 1, wherein the wavelength range of UV for the UV-ozone treatment in step (c) is 150 to 254 nm. Claim 7 A method for manufacturing a dental implant according to claim 1, wherein the UV flux density for the UV-ozone treatment in step (c) is 20 mW / ㎠ to 1.0 W / ㎠. Claim 8 A method for manufacturing a dental implant according to claim 7, wherein the UV flux density for the UV-ozone treatment in step (c) is 45 mW / cm² to 0.2 W / cm². Claim 9 A method for manufacturing a dental implant according to claim 1, wherein the temperature inside the reaction chamber for the UV-ozone treatment of step (c) is 10 to 80°C. Claim 10 A method for manufacturing a dental implant according to claim 1, wherein the UV treatment time for the UV-ozone treatment in step (c) is 1 minute to 1 hour. Claim 11 A method for manufacturing a dental implant according to claim 1, further comprising: (d) immersing at least a portion of the titanium substrate modified to a superhydrophilic surface in a second solution containing a divalent metal salt. Claim 12 In claim 11, the above divalent metal salt is Mg 2+ , Ca 2+ , Sr 2+ , Mn 2+ and Zn 2+ A method for manufacturing a dental implant comprising one or more divalent metal ions selected from the group consisting of Claim 13 A method for manufacturing a dental implant according to claim 12, wherein the concentration of the divalent metal ion is 0.01 mol / L to 0.5 mol / L. Claim 14 A dental implant, wherein the surface of a titanium substrate having a silver-titanium oxide matrix formed thereon is modified into a superhydrophilic surface having a surface contact angle of 5° or less by UV-ozone treatment, and the silver-titanium oxide matrix has a peak P1 with a binding energy of 570–580 eV and a peak P2 with a binding energy of 360–375 eV measured by XPS, and the intensity I1 of P1 and the intensity I2 of P2 satisfy the following equation, and wherein the dental implant emits silver of at least 1 ppb / day and at least 1 ppm / day for at least one week in an inorganic solvent at 37°C: [Equation] 3.4*I1≤I2≤3.6*I1. Claim 15 delete
Citation Information
Patent Citations
Gradient coating for biomedical applications
JP2019150648A
Hardenable dental compositions comprising basic core material encapsulated in an inorganic shell and dispensing devices therewith
US20210228315A1
Method of preparing silver-bearing titanium dioxide thin film on surface of medical titanium or titanium alloy
CN103877618A
Method for Preparing Dental Implants with Improved Surface Morphology and Osseointegration
KR101972122B1
